maintenance on semaglutide Weight after discontinuation of GLP-1 therapies How Long Should You Stay

Frequently Asked Questions What is the best brand-name GLP-1 telehealth provider in 2026

A tracking system tells you whether it is working

10% excreted unchanged by the kidney contraindicated: hepatic dysfunction renal insufficiency Glimepiride: (Amaryl) monotherapy -- once a day administration or in combination with insulin most potent -- lowest dose of the sulfonylureas long duration of action: half-life = 5 hours hepatic metabolism: complete to inactive products Secondary Failure and Tachyphylaxis to Sulfonylureas: Treatment failures occur Possibly due to pancreatic B cell refractoriness or to loss of dietary compliance Combination of sulfonylureas and insulin would appear justified only in the presence of severe insulin resistance Metformin: (Glucophage) glycolysis stimulation-- increased glucose removal from blood decreased hepatic gluconeogenesis decreased glucose absorption rate from the GI tract reduced plasma glucagon in patients with refractory obesity and insulin resistance Advantages: does not cause hypoglycemia does not increased weight May be used in combination with sulfonylureas when sulfonylurea monotherapy is not effective most common -- gastrointestinal (20% frequency) anorexia, nausea, vomiting, diarrhea dose-related usually occurs upon initiation of therapy -- often transient in effect Decreased vitamin B 12 absorption

If something goes wrong, you have little recourse

In younger patients with no risk factors for colorectal cancer or intestinal diseases, a sigmoidoscopy may suffice

Many conditions alter GSH level via changes in GCS activity and GCS gene expression